BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17876053)

  • 1. Involvement of specific matrix metalloproteinases during tumor necrosis factor/IFNgamma-based cancer therapy in mice.
    Van Roy M; Van Lint P; Van Laere I; Wielockx B; Wilson C; López-Otin C; Shapiro S; Libert C
    Mol Cancer Ther; 2007 Sep; 6(9):2563-71. PubMed ID: 17876053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy.
    Wielockx B; Lannoy K; Shapiro SD; Itoh T; Itohara S; Vandekerckhove J; Libert C
    Nat Med; 2001 Nov; 7(11):1202-8. PubMed ID: 11689884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of tissue inhibitors of matrix metalloproteinases to increase the efficacy of a tumor necrosis factor/interferon gamma antitumor therapy.
    Van Roy M; Wielockx B; Baker A; Libert C
    Cancer Gene Ther; 2007 Apr; 14(4):372-9. PubMed ID: 17218947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cigarette smoke upregulates pulmonary vascular matrix metalloproteinases via TNF-alpha signaling.
    Wright JL; Tai H; Wang R; Wang X; Churg A
    Am J Physiol Lung Cell Mol Physiol; 2007 Jan; 292(1):L125-33. PubMed ID: 16905636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of airway remodeling-associated mediators by the antifibrotic compound, pirfenidone, and the matrix metalloproteinase inhibitor, batimastat, during acute lung injury in mice.
    Corbel M; Lanchou J; Germain N; Malledant Y; Boichot E; Lagente V
    Eur J Pharmacol; 2001 Aug; 426(1-2):113-21. PubMed ID: 11525779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis.
    Nemeth JA; Yousif R; Herzog M; Che M; Upadhyay J; Shekarriz B; Bhagat S; Mullins C; Fridman R; Cher ML
    J Natl Cancer Inst; 2002 Jan; 94(1):17-25. PubMed ID: 11773278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase inhibition facilitates cell death in intracerebral hemorrhage in mouse.
    Grossetete M; Rosenberg GA
    J Cereb Blood Flow Metab; 2008 Apr; 28(4):752-63. PubMed ID: 17971790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increments in cytokines and matrix metalloproteinases in skeletal muscle after injection of tissue-damaging toxins from the venom of the snake Bothrops asper.
    Rucavado A; Escalante T; Teixeira CF; Fernándes CM; Diaz C; Gutiérrez JM
    Mediators Inflamm; 2002 Apr; 11(2):121-8. PubMed ID: 12061424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94.
    Asahi M; Asahi K; Jung JC; del Zoppo GJ; Fini ME; Lo EH
    J Cereb Blood Flow Metab; 2000 Dec; 20(12):1681-9. PubMed ID: 11129784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TIMP-3 and MMP-3 contribute to delayed inflammation and hippocampal neuronal death following global ischemia.
    Walker EJ; Rosenberg GA
    Exp Neurol; 2009 Mar; 216(1):122-31. PubMed ID: 19111539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of MMP-2 (gelatinase A) and MMP-9 (gelatinase B) by interferon-gamma in a human salivary gland cell line.
    Wu AJ; Lafrenie RM; Park C; Apinhasmit W; Chen ZJ; Birkedal-Hansen H; Yamada KM; Stetler-Stevenson WG; Baum BJ
    J Cell Physiol; 1997 May; 171(2):117-24. PubMed ID: 9130458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of matrix metalloproteinases in delayed neuronal damage after transient global cerebral ischemia.
    Lee SR; Tsuji K; Lee SR; Lo EH
    J Neurosci; 2004 Jan; 24(3):671-8. PubMed ID: 14736853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine-dependent invasiveness in B16 murine melanoma cells: role of uPA system and MMP-9.
    Bianchini F; D'Alessio S; Fibbi G; Del Rosso M; Calorini L
    Oncol Rep; 2006 Mar; 15(3):709-14. PubMed ID: 16465434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparate effects of MMP and TIMP modulation on coronary atherosclerosis and associated myocardial fibrosis.
    Kremastiotis G; Handa I; Jackson C; George S; Johnson J
    Sci Rep; 2021 Nov; 11(1):23081. PubMed ID: 34848763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase-9 promotes neutrophil migration and alveolar capillary leakage in pancreatitis-associated lung injury in the rat.
    Keck T; Balcom JH; Fernández-del Castillo C; Antoniu BA; Warshaw AL
    Gastroenterology; 2002 Jan; 122(1):188-201. PubMed ID: 11781293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MMP inhibition modulates TNF-alpha transgenic mouse phenotype early in the development of heart failure.
    Li YY; Kadokami T; Wang P; McTiernan CF; Feldman AM
    Am J Physiol Heart Circ Physiol; 2002 Mar; 282(3):H983-9. PubMed ID: 11834496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation.
    Hofmann UB; Eggert AA; Blass K; Bröcker EB; Becker JC
    Cancer Res; 2003 Dec; 63(23):8221-5. PubMed ID: 14678978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) by bone resorptive factors in osteoblastic cells.
    Uchida M; Shima M; Shimoaka T; Fujieda A; Obara K; Suzuki H; Nagai Y; Ikeda T; Yamato H; Kawaguchi H
    J Cell Physiol; 2000 Nov; 185(2):207-14. PubMed ID: 11025442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional significance of MMP-9 in tumor necrosis factor-induced proliferation and branching morphogenesis of mammary epithelial cells.
    Lee PP; Hwang JJ; Murphy G; Ip MM
    Endocrinology; 2000 Oct; 141(10):3764-73. PubMed ID: 11014232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of matrix metalloproteinases (MMP-2, -7, -9) and their tissue inhibitors (TIMP-2, -3) in the regression of chicken postovulatory follicles.
    Hrabia A; Socha JK; Sechman A
    Gen Comp Endocrinol; 2018 May; 260():32-40. PubMed ID: 29438675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.